BioAtla, Inc. (NASDAQ:BCAB) filed a Form 8-K with the Securities and Exchange Commission on February 06, 2026, disclosing a material event.
BioAtla, Inc.'s stock currently trades at $0.21 with a market capitalization of $46.1M. The Healthcare company's stock moved following the disclosure.